Sphere Fluidics Files two new (US and GB) Patents

Sphere Fluidics has filed two new patents, one a national filing in the US and the other a new UK filing, on picodroplet technology. “We now have 8 patent families comprising 40 international patents (21 of which are granted)” said Dr Frank F. Craig (CEO). “We have a world-class portfolio and freedom-to-operate in our chosen Fields. This represents a superb asset for both us and our commercial partners”.

Sphere Fluidics Nominated as a Finalist in the 2013 UK Business Angels Association (UKBAA) Awards

Sphere Fluidics has been nominated as a finalist in two separate UKBAA awards categories: i) Best Early Stage Investment in a Disruptive Technology Business, and ii) Angel-VC Deal of the Year. Dr Frank F. Craig (CEO) said “It is great that the UKBAA has recognised Sphere Fluidics and our investors as being one of the best teams in the UK.” The Awards Ceremony will be held in London on the 2nd of July. More information can be found here.

Sphere Fluidics Relocates to New Larger Facility at Babraham Research Campus

Sphere Fluidics has now relocated to its new integrated lab and office space at the Jonas Webb Building on Babraham Research Campus. The new building was officially opened today by Rt Hon David Willetts MP (Minister for Universities and Science) who also met with Dr Frank F. Craig (CEO of Sphere Fluidics) who said “We are very pleased to move to such an excellent facility which we have designed to be “state-of-the-art”. This is all part of our plans to enable growth of our business and to accommodate the recruitment of new staff”.

Dr Rob Marchmont joins Sphere Fluidics as their new Commercial Director 

Dr Rob Marchmont, who previously held Senior commercial positions at NanoInk and GE Healthcare and has more than 25 years’ experience in the Life Sciences market, has now joined Sphere Fluidics, to help further grow the business, as their new Commercial Director. Dr Marchmont says “I am thrilled to be joining the Sphere Fluidics team and look forward to building the business based on the success already gained and developing new markets for single cell analysis technology”. Dr Frank F. Craig, CEO, said “Rob is a great addition to our team and I look forward to working with him as we accelerate growth of our business”.

Sphere Fluidics' Scientific Founders win European ACES Entrepreneurial Prize for Best University Life Sciences Spin-Out

Professors Chris Abell and Wilhelm Huck of Cambridge University and Radboud University, Nijmegen respectively were awarded an international prize for their enterprise in creating and developing Sphere Fluidics. Dr Andrew Mackintosh, the Chairman of Sphere Fluidics, collected the prize on the Founder’s behalf in a prize-giving ceremony in Brussels. “Chris and Wilhelm are a superb example of world-class scientists who are also entrepreneurial and help commercialise their technology in exciting new spin-outs”. More information on the award can be found here.

Sphere Fluidics to attend "Empowered Antibodies Congress"

Dr Xin Li (Group Leader, Chemistry) of Sphere Fluidics will be attending the “Empowered Antibodies Congress” to be held in Barcelona on June 11th–13th, 2013. “This conference gives an excellent opportunity to learn from industry leaders about antibody discovery and new ADC technology. We also believe that our Cyto-Mine technology for single cell analysis may be of interest to enable novel immunology studies with libraries of cells or nascent biotherapeutics. More conference information can be found here.

Sphere Fluidics to Attend "Forum Labo Biotech" Conference

Dr Frank F. Craig, CEO of Sphere Fluidics Limited, will be attending the “Forum Labo Biotech” Conference to be held in Paris (France) on 4th–7th of June, 2013. “The French Life Sciences market is one of the biggest in Europe. Forum Labo is an excellent, biannual conference where we can meet with potential customers and alliance partners and also view new products emerging on the market”, says Dr Craig. More information on the conference can be found here.